MARKET AND REFERENCE RECORDS
Why one generic name cannot settle an “originator/generic” question
Originator, reference, authorised generic and generic medicine records depend on the regulatory market and the exact product. Fix the market, dosage form, route, strength and holder before comparing anything.
Start with one exact product in one market
A medicine name is a search entry, not a complete product identity. The same non-proprietary name can have different approval pathways, brands, holders, strengths, forms, routes and label versions across markets. Record the intended market, brand and non-proprietary name, dosage form, route, strength and any visible approval or holder clue before making a comparison.
A reference record is not cross-market proof of originator status
China’s listed-drug directory and reference-product notices are the starting points for local records. In the United States, the Orange Book records Reference Listed Drugs, Reference Standards, application type, dosage form, route and therapeutic-equivalence information under its own rules. A research reference in one market does not establish brand ownership, approval, supply, interchangeability or originator status in another.
Generic, authorised generic and brand products need separate checks
FDA explains that an ANDA generic application is evaluated against a specific RLD and bioequivalence pathway. An authorised generic may be sold under the brand product’s NDA and need not appear as a separate Orange Book entry. In the EU, a generic application relies on an authorised reference medicine, while names, presentation, pack and inactive ingredients can differ. A missing brand name or a different pack does not prove any product category or authenticity.
Form and route decide whether comparison is possible
Tablets, delayed- or modified-release products, oral liquids, injections, inhalers, topical products and patches are not interchangeable descriptions of a generic name. Product records are usually organised by dosage form, route and strength. The same active ingredient does not make products a valid comparison group when release behaviour, route or strength differs.
What a photograph can and cannot do
A pack or leaflet photo can help organise name, strength, form, batch and market clues, then lead to possible records. It cannot establish authenticity, approval, originator status, individual suitability or cross-border sale eligibility. For an unknown product, a serious suspected adverse effect or an urgent concern, contact local clinical or pharmacy support rather than relying on image comparison.
PRIMARY REFERENCE
Source entry points
Each original source must be checked for its current version, market and scope before use. Read the editorial method.